Amarex Clinical Research, LLC, an NSF International company, is pleased to announce that Amarex Taiwan, LLC will keynote at BioAsia-Taiwan 2020 Online + Live. BioAsia-Taiwan 2020 will be held digitally on July 22-26. This conference brings together biotechnology and pharmaceutical leaders from around the globe to explore biotech developments and business opportunities with a focus on activities and companies in Asia.
On Friday, July 24, President & CEO of Amarex Taiwan, Dr. Kazem Kazempour, will keynote at Workshop 2 on the topic of Clinical Trials for Advances Therapies.
The design of clinical trials for advanced therapies often differs from the design of clinical trials for other types of pharmaceutical products. In this talk, Dr. Kazempour will focus on the challenges at the design and analysis stages of clinical development for advanced therapy products, including sample size and power calculations needed to establish efficacy. By identifying the challenges of these innovative and complicated clinical trial designs, we can offer strategies from different perspectives to overcome them. There are also multiple opportunities to take advantage of special programs at different stages of clinical development, including the utilization of Expedited Programs.
Additional presentations in this workshop will cover advanced immunotherapy, oncology trial design and regulatory considerations for evaluation of regenerative medicine products.
To view the agenda or to register for BIO Asia-Taiwan 2020, visit https://bioasiataiwan.com/.